Harry J. McGaw is an expert in the field of Hematology. He graduated from Louisiana State University School of Medicine in New Orleans. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Harry McGaw is also a published physician. He has 2 publication published. The most recent publication is: Phase II study of docetaxel in advanced soft tissue sarcomas. He is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1750479515 | |
NPPES Provider LastName | MCGAW | |
NPPES Provider FirstName | HARRY | |
NPPES Provider ZIPCode | 703603403 | |
NPPES Provider State | LA | |
Specialty Description | Medical Oncology | |
Total Claim Count | 811.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 138.0 | |
Percent Opioid Claims | 17.02 |
National Provider Identifier [NPI] | 1750479515 |
Last Name Of The Provider | MCGAW |
First Name Of The Provider | HARRY |
View All |
![]() |
Dr. John M. Kennedy, MD
![]() |
![]() |
Dr. Naveed A. Khan, MD |
![]() |
Dr. Robert K. Gamble, MD |
![]() |
Dr. Raul Doria, MD
![]() |